Bank of America’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-135,297
| Closed | -$2.73M | – | 8964 |
|
|
2021
Q3 | $2.73M | Sell |
135,297
-113,124
| -46% | -$3.12M | ﹤0.01% | 4145 |
|
|
2021
Q2 | $9.27M | Buy |
248,421
+18,956
| +8% | +$581K | ﹤0.01% | 2923 |
|
|
2021
Q1 | $5.87M | Buy |
229,465
+51,411
| +29% | +$1.31M | ﹤0.01% | 3251 |
|
|
2020
Q4 | $3.92M | Sell |
178,054
-57,511
| -24% | -$1.27M | ﹤0.01% | 3356 |
|
|
2020
Q3 | $4.24M | Buy |
235,565
+18,878
| +9% | +$391K | ﹤0.01% | 3061 |
|
|
2020
Q2 | $5.5M | Buy |
216,687
+59,383
| +38% | +$1.28M | ﹤0.01% | 2745 |
|
|
2020
Q1 | $2.89M | Buy |
157,304
+39,845
| +34% | +$774K | ﹤0.01% | 3183 |
|
|
2019
Q4 | $2.59M | Sell |
117,459
-91,595
| -44% | -$1.84M | ﹤0.01% | 3818 |
|
|
2019
Q3 | $3M | Buy |
209,054
+142,242
| +213% | +$2.03M | ﹤0.01% | 3681 |
|
|
2019
Q2 | $1.05M | Sell |
66,812
-107,749
| -62% | -$1.47M | ﹤0.01% | 4529 |
|
|
2019
Q1 | $2.56M | Buy |
174,561
+163,965
| +1,547% | +$1.88M | ﹤0.01% | 3788 |
|
|
2018
Q4 | $113K | Buy |
10,596
+2,465
| +30% | +$32.4K | ﹤0.01% | 5848 |
|
|
2018
Q3 | $124K | Sell |
8,131
-1,079
| -12% | -$15.7K | ﹤0.01% | 5773 |
|
|
2018
Q2 | $113K | Buy |
9,210
+719
| +8% | +$9.03K | ﹤0.01% | 5734 |
|
|
2018
Q1 | $81K | Buy |
8,491
+8,456
| +24,160% | +$91.2K | ﹤0.01% | 5835 |
|
|
2017
Q4 | $0 | Sell |
35
-362
| -91% | -$2.66K | ﹤0.01% | 7360 |
|
|
2017
Q3 | $2K | Buy |
397
+362
| +1,034% | +$1.32K | ﹤0.01% | 6885 |
|
|
2017
Q2 | $0 | Hold |
35
| – | – | ﹤0.01% | 7277 |
|
|
2017
Q1 | $0 | Sell |
35
-1,060
| -97% | -$2.98K | ﹤0.01% | 7348 |
|
|
2016
Q4 | $3K | Buy |
1,095
+910
| +492% | +$3.23K | ﹤0.01% | 6804 |
|
|
2016
Q3 | $1K | Sell |
185
-7,141
| -97% | -$25K | ﹤0.01% | 7008 |
|
|
2016
Q2 | $22K | Buy |
7,326
+5,396
| +280% | +$22.2K | ﹤0.01% | 6211 |
|
|
2016
Q1 | $11K | Sell |
1,930
-1,870
| -49% | -$11.8K | ﹤0.01% | 6372 |
|
|
2015
Q4 | $45K | Buy |
3,800
+3,582
| +1,643% | +$41K | ﹤0.01% | 6086 |
|
|
2015
Q3 | $2K | Sell |
218
-405
| -65% | -$4.68K | ﹤0.01% | 6992 |
|
|
2015
Q2 | $9K | Buy |
623
+448
| +256% | +$8.22K | ﹤0.01% | 6631 |
|
|
2015
Q1 | $4K | Sell |
175
-2,855
| -94% | -$64.2K | ﹤0.01% | 6578 |
|
|
2014
Q4 | $50K | Sell |
3,030
-8,870
| -75% | -$102K | ﹤0.01% | 6347 |
|
|
2014
Q3 | $151K | Buy |
11,900
+8,355
| +236% | +$126K | ﹤0.01% | 5660 |
|
|
2014
Q2 | $80K | Sell |
3,545
-1,455
| -29% | -$26.4K | ﹤0.01% | 6312 |
|
|
2014
Q1 | $141K | Buy |
+5,000
| New | +$186K | ﹤0.01% | 5706 |
|
Other funds holding DRNA
Bank of America's DRNA Position: Q4 2021 in Review
Bank of America sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 135,297 shares — an estimated $2.73M sold.
Bank of America first reported a position in DRNA in Q1 2014 and held it in 31 quarters. The position peaked at $9.27M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- Bank of America reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- Bank of America sold 135,297 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $2.73M.
- Bank of America first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2014 and held it in 31 quarters.
- Bank of America's Dicerna Pharmaceuticals, Inc. position peaked at $9.27M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on Bank of America's 13F filing for Q4 2021, filed 8 Feb 2022.